Prevalence and Risk Factors of Ocular Hypertension Following Fluocinolone Acetonide (Iluvien®) Intravitreal Injections: The "SAFAC" Study.
Saved in:
| Title: | Prevalence and Risk Factors of Ocular Hypertension Following Fluocinolone Acetonide (Iluvien®) Intravitreal Injections: The "SAFAC" Study. |
|---|---|
| Authors: | Serrar, Yasmine1 (AUTHOR), Sejournet, Lucas1,2 (AUTHOR), Allignet, Benoît3,4 (AUTHOR), Bounetta, Sami1 (AUTHOR), Deiri, Marwa1 (AUTHOR), Gullon, Chloé1 (AUTHOR), Malclès, Ariane5,6 (AUTHOR), Denis, Philippe1 (AUTHOR), Mathis, Thibaud1,2 (AUTHOR), Kodjikian, Laurent1,2 (AUTHOR) laurent.kodjikian@chu-lyon.fr |
| Source: | Ophthalmology & Therapy. Apr2026, Vol. 15 Issue 4, p1341-1353. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 192725727 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prevalence and Risk Factors of Ocular Hypertension Following Fluocinolone Acetonide (Iluvien<superscript>®</superscript>) Intravitreal Injections: The "SAFAC" Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Serrar%2C+Yasmine%22">Serrar, Yasmine</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sejournet%2C+Lucas%22">Sejournet, Lucas</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Allignet%2C+Benoît%22">Allignet, Benoît</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bounetta%2C+Sami%22">Bounetta, Sami</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Deiri%2C+Marwa%22">Deiri, Marwa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gullon%2C+Chloé%22">Gullon, Chloé</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Malclès%2C+Ariane%22">Malclès, Ariane</searchLink><relatesTo>5,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Denis%2C+Philippe%22">Denis, Philippe</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mathis%2C+Thibaud%22">Mathis, Thibaud</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kodjikian%2C+Laurent%22">Kodjikian, Laurent</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> laurent.kodjikian@chu-lyon.fr</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Ophthalmology+%26+Therapy%22">Ophthalmology & Therapy</searchLink>. Apr2026, Vol. 15 Issue 4, p1341-1353. 13p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=192725727 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40123-026-01339-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 1341 Titles: – TitleFull: Prevalence and Risk Factors of Ocular Hypertension Following Fluocinolone Acetonide (Iluvien®) Intravitreal Injections: The "SAFAC" Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Serrar, Yasmine – PersonEntity: Name: NameFull: Sejournet, Lucas – PersonEntity: Name: NameFull: Allignet, Benoît – PersonEntity: Name: NameFull: Bounetta, Sami – PersonEntity: Name: NameFull: Deiri, Marwa – PersonEntity: Name: NameFull: Gullon, Chloé – PersonEntity: Name: NameFull: Malclès, Ariane – PersonEntity: Name: NameFull: Denis, Philippe – PersonEntity: Name: NameFull: Mathis, Thibaud – PersonEntity: Name: NameFull: Kodjikian, Laurent IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 21938245 Numbering: – Type: volume Value: 15 – Type: issue Value: 4 Titles: – TitleFull: Ophthalmology & Therapy Type: main |
| ResultId | 1 |